PapersPMID:35368930
Effect of Resveratrol Combined with Donepezil Hydrochloride on Inflammatory Factor Level and Cognitive Function Level of Patients with Alzheimer's Disease.
What moved
1 findingHow to read these marks →“Compared with CG after treatment, EG obtained obviously higher MMSE score (P < 0.001) and significantly lower ADAS-cog score (P < 0.001) (see Figure 1).”
- Study
- RCT
- Participants
- 90
- Duration
- 2 months
- Dose studied
- 1-2 RES tablets (1.0 g each) daily as a dietary supplement, added to donepezil hydrochloride
- Population
- patients with Alzheimer's disease, all also receiving donepezil hydrochloride as background therapy in both arms (EG: donepezil + resveratrol; CG: donepezil alone), 2-month treatment
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- patients with Alzheimer's disease
- Participants
- 90
- Comparator
- an active treatment / placebo
- Duration
- 61 days
- Endpoints measured
- 7
resveratrol